Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Aloni-Grinstein

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Biotechnology|September 30, 1999
Reconstitution of fibroblast growth factor receptor interactions in the yeast two hybrid systemR Aloni-Grinstein, A Seddon, A Yayon
The EMBO Journal|April 3, 1995
Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expressionR Aloni-Grinstein, D Schwartz, V Rotter
Oncogene|December 1, 1993
Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineageR Aloni-Grinstein, I Zan-Bar, I Alboum, et al.
Infection and Immunity|June 24, 2005
Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigenR Aloni-Grinstein, O Gat, Z Altboum, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Targets for transcriptional activation by wild-type p53: endogenous retroviral LTR, immunoglobulin-like promoter, and an internal promoter of the mdm2 geneY Barak, A Lupo, A Zauberman, et al.
Infection and Immunity|January 24, 2003
Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccinesO Gat, I Inbar, R Aloni-Grinstein, et al.
Vaccine|July 26, 2005
Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin componentsI Mendelson, O Gat, R Aloni-Grinstein, et al.
Seminars in Cancer Biology|June 1, 1994
Does wild-type p53 play a role in normal cell differentiation?V Rotter, R Aloni-Grinstein, D Schwartz, et al.
Cell Death and Differentiation|May 17, 2014
The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either alleleY Shetzer, S Kagan, G Koifman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Biotechnology|September 30, 1999
Reconstitution of fibroblast growth factor receptor interactions in the yeast two hybrid systemR Aloni-Grinstein, A Seddon, A Yayon
The EMBO Journal|April 3, 1995
Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expressionR Aloni-Grinstein, D Schwartz, V Rotter
Oncogene|December 1, 1993
Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineageR Aloni-Grinstein, I Zan-Bar, I Alboum, et al.
Infection and Immunity|June 24, 2005
Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigenR Aloni-Grinstein, O Gat, Z Altboum, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Targets for transcriptional activation by wild-type p53: endogenous retroviral LTR, immunoglobulin-like promoter, and an internal promoter of the mdm2 geneY Barak, A Lupo, A Zauberman, et al.
Infection and Immunity|January 24, 2003
Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccinesO Gat, I Inbar, R Aloni-Grinstein, et al.
Vaccine|July 26, 2005
Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin componentsI Mendelson, O Gat, R Aloni-Grinstein, et al.
Seminars in Cancer Biology|June 1, 1994
Does wild-type p53 play a role in normal cell differentiation?V Rotter, R Aloni-Grinstein, D Schwartz, et al.
Cell Death and Differentiation|May 17, 2014
The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either alleleY Shetzer, S Kagan, G Koifman, et al.
Pageof 1